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Jefferson  
and Nemours 
Partnering Today 
for Healthier  
Tomorrows
Downsizing?  
Facing Capital Gains?
Do you have property that is a burden to manage?
Do you own property you don’t use anymore?
Will you owe significant taxes if you sell your property?
If so, the Jefferson Foundation can help. By donating real estate  
to Jefferson, you can achieve peace of mind, create a lasting legacy  
and receive financial benefits for yourself or someone else.
What’s in it for you?
Depending on the nature of your gift and your objectives,  
you could:
• Avoid capital gains taxes on appreciated property.
•  Eliminate the burden of maintaining and paying  
for the property.
• Provide yourself with an annual income.
• Reduce your estate and income taxes.
The Jefferson Foundation staff will gladly discuss  
the various giving options associated with gifts  
of property and real estate. For more information  
contact Fritz Ruccius at the Jefferson Foundation,  
215-955-8733 or frederick.ruccius@jefferson.edu.
Donate your property — or a portion of it — to Jefferson.
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Many institutions are guided by a sense 
of self-sufficiency. A “we-can-do-it-alone” 
mentality frames their approaches to all 
sorts of things — from closed-shop hospital 
staffing to lopsided inter-institutional 
partnering formulas. other institutions are 
wired differently — imbued instead with 
a sense that “going-it-alone is not the best 
option,” and that so much more is to be 
gained from robust collaboration and inter-
connectedness. Reaching out to multiple 
partners, even in creative ways to titular 
‘competitors,’ becomes a preferable starting 
point. for these institutions, Jefferson 
among them, ‘partnership’ is a core  
value proposition.
We believe that training physicians of 
the future demands partnerships. True, the 
Medical College’s historically large class 
size has made alignment with multiple 
teaching affiliates an imperative. However, 
this is only part of the logic that has driven 
Jefferson’s historical openness to partners. 
Multiple training sites translate into a rich 
training experience for each individual 
student. Attending physicians ensconced in 
diverse practice settings create a tapestry 
of clinical acumen for our students to draw 
upon. And the benefits of Jefferson’s pro-
partnership ethos spillover amply into its 
research and clinical missions as well. 
The Jefferson collaboration mindset 
touches a multiplicity of specialties, disci-
plines and sites. Several of these concentric 
‘partnership spheres’ stand out.
first, three prestigious, world-class 
institutions — Nemours/Alfred I. duPont 
Hospital for Children, Wills Eye Institute 
and Rothman Institute — serve as Jefferson’s 
Pediatrics, ophthalmology and orthopaedics 
departments, respectively (please see page 6  
for Nemours partnership feature story). 
Most medical schools would find it hard to 
even conceive of three core clinical depart-
ments such as these sitting outside their 
‘financial control orbit’ — but not so for 
JMC. We simply leverage their greatness 
and ensure that all boats rise together. The 
fact that these institutions share a visceral 
commitment to all elements of the tripartite 
mission makes this easy.
Second, a web of alliance partners — 
Main line Health System, Christiana Care 
Health Systems in delaware, Virtua Health 
System in New Jersey, Albert Einstein 
Medical Center in Philadelphia, Reading 
and York Hospitals, among them — form 
the backbone of our clinical training 
programs. Approximately 50 percent of 
our third- and fourth-year students are 
in training at these affiliated institutions 
at any one time. There they receive the 
same superb education that they would 
have received at the Center City campuses, 
thanks to our dedicated faculty. We 
emphasize open communication with 
our affiliate faculty members and meet 
with them regularly to review curricular 
changes, thus ensuring that the education 
our students receive on any rotation is 
equally rich at all sites. 
Third, other regional universities are 
part of Jefferson’s universe of academic and 
research partnerships. There is a robust and 
growing set of links between Jefferson and 
the university of delaware. We have served as 
the medical school for the State of delaware 
for many years, and ud has been a linchpin 
in our mission-critical bridge to delaware, 
alongside Christiana Care and Nemours. In 
fact, our four institutions have in recent years 
been knitted together under the banner of the 
delaware Health Sciences Alliance. 
Another exciting university partnership 
has been cultivated with drexel university. 
Most notably, drexel’s School of Medicine 
The Dean’s Column
was brought into Jefferson’s Kimmel Cancer 
Center, in the course of the recent cancer 
center core grant renewal by the National 
Cancer Institute. This represents a most 
significant development — a wonderful 
example of two medical schools in one city 
coming together for a common academic 
purpose. Now, drexel and Jefferson scien-
tists alike can benefit from the research 
core support that KCC has to offer. With 
outstanding leaders at the helms of their 
university and medical school, we are 
poised to explore additional collaborative 
opportunities with drexel. In these resource-
constrained times, institutions that were 
once pitted as ‘competitors’ can sometimes 
be better served by re-imagining themselves 
as partners — a new take on the coined term 
‘coopetition’, or cooperative competition. 
Much is said in the press about the 
necessity to be ‘competitive’ in all spheres 
of 21st century human endeavor. our 
nation is asked to be more competitive 
when facing off against other countries. 
our healthcare institutions are asked to  
be more competitive in matching up 
against other regional and national 
players. But paradoxically perhaps, in 
some instances competitiveness may 
actually be enhanced by cooperation and 
redefining whom the competition really 
is out there. Historically, cooperation has 
proved good for Jefferson and its missions. 
looking to the future, it also bodes well 
for the greater good.
Mark l. Tykocinski, Md 
Anthony F. and Gertrude M. DePalma Dean 
Jefferson Medical College
We believe that training 
physicians of the future 
demands partnerships.
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A newly discovered function of the enzyme 
PARP-1 could be the key to more effective 
therapeutics for advanced prostate cancer 
patients, a recent preclinical study by 
researchers at Jefferson’s Kimmel Cancer 
Center suggests.
The team, led by Karen Knudsen, Phd, 
professor in the department of Cancer 
Biology, found that functions of PARP-1  
not only include dNA damage repair but 
also androgen receptor (AR) regulation 
in advanced prostate cancer growth and 
progression. Inhibiting PARP-1 in  
various models, the researchers found,  
also suppressed AR activity, which fuels 
prostate growth. 
Researchers believe that the dual function 
of PARP-1 — both AR and dNA damage 
function — could be leveraged for therapeutic 
benefit. New PARP-1 inhibitors targeting both 
could slow down advanced-stage prostate 
cancer patients and shrink tumors, the team 
surmises. 
“We hope to capitalize on this previously 
unknown function in PARP-1 in prostate 
cancer,” Knudsen says. “our data show that 
PARP-1 plays a major role in controlling AR 
function and that, when suppressed with 
inhibitors, enhanced anti-tumor effects of 
castration and delayed onset to castration 
resistance. This is the basis to support a 
clinical trial investigating new PARP-1 
inhibitors in these patients.”
Today, PARP-1 is seen as a valuable target 
because of its involvement in dNA repair for 
cancer cells. The therapy has been successful 
when combined with dNA-damaging drugs 
because it heightens the apoptotic activity 
of these drugs. In other words, it helps halt 
tumor growth, but only by stopping dNA 
repair in various cancers.  
Prostate cancer is dependent on AR 
activity for growth and survival, and is 
largely resistant to standard chemotherapy. 
AR-directed therapies are the first-line 
intervention for patients with advanced 
disease; however, recurrent tumors arise when 
AR is reactivated, a common occurrence in 
the castrate-resistant stage of the disease. 
Therefore, there is a dire need to develop 
means to suppress the AR function in these 
patients. With this new role defined, newly 
designed PARP-1 inhibiters targeting both 
functions could sensitize prostate cancer, 
so AR-directed therapies can perform their 
intended function in these patients, the 
researchers suggest in the paper.
Almost 40 percent of men with prostate 
cancer progress into an advanced stage, 
including castrate-resistant prostate cancer, 
where chemotherapy and other therapies have 
little to no effect.
using various in vitro and in vivo 
genetically defined model systems and 
applying an analysis known as ChIP 
sequencing, the researchers found that 
PARP-1 activity is required for AR function 
and is increased in castrate-resistant prostate 
cancer. What’s more, inhibiting PARP-1 
suppressed proliferation of primary human 
cancer cells.
“These findings introduce a paradigm shift 
with regard to PARP-1 in prostate cancer,” 
Knudsen says, “and provide the basis for new 
therapies that could help a whole population 
of cancer patients who have little options.”
faculty from across Jefferson participated 
in the study, with key co-authors including 
leonard gomella, Md, chair of the 
department of urology; Peter McCue, Md, 
professor in the department of Pathology, 
Anatomy and Cell Biology; Jonathan Brody, 
Phd, assistant professor in the department of 
Surgery; John Pascal, Phd, assistant professor 
in the department of Biochemistry and 
Molecular Biology; and Adam dicker, Md, 
Phd, chair of the department of Radiation 
oncology. A P01 grant to fund future clinical 
trials is pending and will support the work of 
Jefferson’s team as well as researchers from 
the university of Michigan and Memorial 
Sloan Kettering Cancer Center.   
findings
One of the functions of the PArP-1 enzyme 
is illustrated to show how it plays a role in 
the repair of damaged Dna in cancer cells.  
Targeting Dual roles of ParP-1 may slow Cancer Growth
The PArP-1 enzyme 
repairs the damaged 
Dna, resulting in cell 
proliferation and  
tumor growth. 
researchers have found 
that treating a patient 
with a PArP-1 inhibitor 
results in an increase in 
cancer cell death.
PArP-1 is recruited 
to the location of 
the Dna damage.
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a newly discovered function of the PArP-1 
enzyme is its protumorigenic effects in the 
androgen receptor (Ar) of positive prostate 
cancer cells. Prostate cancer is dependent 
on ar activity for growth and survival and 
is resistant to standard chemotherapy. The 
illustration shows how the process of ar 
function and the ParP-1 enzyme work together 
to grow and regenerate the cancer cell.
Once in the nucleus, 
the ParP-1 enzyme 
is recruited to the site 
of Ar function.
ParP-1 enzymatic activity is increased. The 
process of transcription* of the Dna occurs 
— a vital event in the life of the cell — and the 
cancer cell survives. 
research has shown that the inhibition of 
the ParP-1 enzyme stops the ar activity, 
preventing the cell from surviving the  
damaging effects of chemotherapy.
Androgenic hormones 
such as testosterone or 
dihydrotesterone found 
in the cellular wall bind with 
the androgen receptor and 
begin translocation, or the 
process of the ar moving 
into the cell nucleus.
Ar
PArP-1
* transcription (n) 
The process by which messenger rna is 
synthesized from a Dna template resulting 
in the transfer of genetic information from 
the Dna molecule to the messenger rna.
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magine you just turned 21. You have 
had ulcerative colitis since you were 8. 
It has been closely managed by your 
pediatricians, but now that you are an adult, 
they can no longer treat you. Your condi-
tion hasn’t gone away — but your medical 
support team has. What do you do? Where 
do you go for your healthcare needs?
“The department of pediatrics at Nemours/ 
Alfred I. duPont Hospital for Children is 
actually the academic home for pediatrics 
at Jefferson,” says Jay greenspan, Md, 
professor and chair, department of Pediatrics. 
“At the same time, Jefferson has incredibly 
strong divisions like gastroenterology. So 
for our pediatric patients with ulcerative 
colitis or who are diagnosed with liver 
failure and have a transplant at Nemours, 
the obvious place for the next stage of their 
care is Jefferson. But that handoff doesn’t 
exist today — so our goal is to help these 
patients make a smooth transition to  
adult care.”
thirty years of Partnering  
Pave the Way
located in Wilmington, del., Nemours 
began partnering with Jefferson in the  
early 1980s. Pediatrics is a core element  
of medical education, but at that time,  
the Jefferson pediatrics department was 
limited. delaware had Nemours, a stellar 
pediatrics hospital located just a few miles 
south of Philadelphia on Interstate 95, but  
it didn’t have a medical school. Partnering 
answered the needs of both organizations. 
Today, Jefferson serves as the medical 
school of delaware, and its students train at 
the department of pediatrics at Nemours. 
“Students are very much embedded in 
day-to-day patient care,” says greenspan. 
“The six-week pediatrics rotation is usually 
at Nemours, which has the largest patient 
base in the Jefferson system.* Students are 
our eyes and ears, and they present patient 
cases first in rounds.”  In addition to 
training students on rotation, Nemours 
provides clinical experience for pediatric 
residents and fellows.
“The relationship is incredibly important 
for both sides,” says greenspan. “for 
Jefferson, it allows us to train effectively 
with an appropriate caseload, which  
reinforces our reputation as a top-notch 
medical school, and for Nemours, it provides 
the opportunity to have a connection with a 
major academic medical center.” 
Nemours and Jefferson collaborate on 
multidisciplinary pediatric programs for 
chronic or complex medical conditions, 
partner on important research studies  
and coordinate care as needed, such as 
facilitating the transfer of extremely ill 
patients from Jefferson to Nemours.  
“It’s a vital relationship that both 
Jefferson and Nemours can be proud of,” 
says Kevin Churchwell, Md, chief executive 
officer for Nemours. “The continued devel-
opment of our relationship is important for 
pediatrics in this region and nationally. 
Any way you look at it — from an academic 
standpoint, a patient-service standpoint or 
a research standpoint, Nemours being the 
pediatric home for Jefferson creates a great 
environment for success.” 
A significant challenge for the two  
partners is the 25-mile distance between 
campuses. “We’re working on improving 
communication and collaboration to help 
solve that obstacle,” says Churchwell.  
“We want to be more intentional about how 
we continue to support clinical program 
development, academic development and 
research development.”  
“The challenge of our physical distance 
from each other is one that we will never  
be able to change,” agrees greenspan. “But 
we can overcome that hurdle as people 
recognize how strong both partners are in 
this relationship and how important it is to 
the future of both institutions to strengthen 
that relationship.”
Working closely together, the two  
institutions provide pediatric care to the 
region’s children both in Wilmington and 
at a satellite pediatrics site in Philadelphia. 
“By aligning our strategies and leveraging 
Jefferson and Nemours: 
Partnering for Pediatric Patients
A vision of seamless transition to adult care
By gail luciani
* Other affiliate institutions where students train include main Line Health system, Virtua Health system, albert 
einstein medical Center, Christiana Care Health system, reading Hospital and York Hospital.
I
Story Summary
 Nemours/alfred I. dupont hospital  
for Children is the academic home for  
pediatrics at Jefferson.
 working closely together, the two  
institutions provide high-quality  
pediatric care to the region’s children 
both in wilmington and at a satellite 
pediatrics site in philadelphia.
 seamlessly transitioning pediatric 
patients to Jefferson will benefit the 
hospitals and patients alike.
 the launch of a new women and  
children’s service line represents a 
renewed focus on the future of health 
care for both women and children  
at Jefferson.
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Jay Greenspan, mD, with a newborn at 
nemours. Photo by Cynthia Brodoway, 
courtesy of nemours/alfred I. duPont 
Hospital for Children.
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institutional strengths, we are advancing 
the care of children both at Nemours and 
on the Jefferson campus,” explains Pauline 
Corso, practice administrator at Nemours. 
Women and children service  
line launched
In June 2012, Jefferson launched “women 
and children,” its sixth service line. An 
outcome of long-term strategy planning, it 
was born of a newfound focus on the future 
of health care for both women and children. 
Initiatives are currently in the development 
stage and include the participation of 
Nemours as the primary practice site for 
pediatrics. “All of our discussions start with 
‘What’s best for the patients?’ then we work 
backwards to deal with logistical challenges. 
for example, which services should be on 
the Philadelphia campus, and which should 
be in Wilmington? Managing the geographic 
distance between the two campuses is a 
significant part of the discussion,” says 
William Schlaff, Md, the Paul A. and  
Eloise B. Bowers Professor and chair of the 
department of obstetrics and gynecology. 
“And within a local context, we need to 
address programs like the expansion of 
obstetrical services and how that impacts 
pediatrics and neonatal intensive care.”
New perinatal programs will go beyond 
re-engineering obstetrics at Jefferson, given 
the opportunity to collaborate across the 
organization. “High-risk obstetrics tends  
to focus on caring for the fetus, and not  
the sick mother. So one of the initiatives  
we are looking at is integrating with the 
department of Medicine to treat women 
with medical problems who are pregnant  
adult medical care very difficult after being 
cared for by a children’s hospital for most of 
their lives,” says Corso. “So our partnership 
with Jefferson positions us well to help 
make this transition smoother for patients 
and families.”
learning to seamlessly transition  
pediatric patients to Jefferson will benefit 
the hospitals and patients alike. By taking 
advantage of connections in every specialty, 
from family practice to cardiac disease, adult 
care could be handled by a Jefferson provider. 
“This is important for our patients but also 
for Jefferson’s longevity, because that’s 
where many of our patients are going to 
come from in the future,” says greenspan. 
Children with chronic disease make  
up one of the most challenging patient 
populations to hit the triple targets of 
improving quality, enhancing access and 
reducing costs because they struggle with 
their conditions for a very long time. In the 
past, they wouldn’t have survived into 
adulthood. “Jefferson is uniquely positioned 
to manage them efficiently, and as we do 
that, we will improve the bottom line of our 
business,” says greenspan. “If we leverage it 
properly, we can be the medical home for 
kids with complex disease throughout the 
world because partnerships between pediat-
rics and adult institutions are rare.”
In addition to partnering on pediatric 
training and clinical care, there is an 
expanding research relationship that spans 
basic lab work and clinical studies at both 
institutions. Jefferson professors, associate 
professors and assistant professors at all 
levels are working in labs, in the clinical 
arena and in the outpatient area of 
Nemours. one reason that research has 
been growing steadily since 2000 is that 
or who want to become pregnant,” says 
Schlaff. “We want to be the place that takes 
care of these patients most safely. By defining 
most of our initiatives as multidisciplinary — 
having the support of medicine, cardiology, 
neonatal ICus and other specialties — we 
can leverage our institutional strength to 
provide something unique to patients that 
they couldn’t get somewhere else.” 
Planning for the future
The launch of the new women and children’s 
service line is just the beginning. In the 
future, tools like single medical records 
maintained across lifetimes could support 
continuity of care for pediatric patients 
entering the adult medical arena. Combined 
pediatric and adult centers of excellence, 
with partner institutions sharing space and 
other resources, could be positioned to 
provide the next generation of patient care. 
Today, Nemours and Jefferson enjoy a 
collaborative partnership in their transplant 
departments, which sets the stage for other 
opportunities. “We see all sorts of possible 
connections between Nemours and Jefferson, 
and with a little bit of effort, we can make 
both institutions stronger,” says greenspan. 
“for example, Nemours is a leader in pediatric 
orthopaedics, and Jefferson is a leader in 
orthopaedics, so if Jefferson has a pediatric 
patient with an orthopaedic problem, we 
should automatically refer him to Nemours 
rather than another children’s hospital in 
Philadelphia. Together, we can be number 
one in orthopaedics.”
like most pediatric departments across 
the united States, transitioning pediatric 
patients to adult medical care is a critical 
issue for Nemours. “Children with chronic 
health conditions can find progressing to 
“ The continued development  
of our relationship is important  
for pediatrics in this region  
and nationally.” — Kevin Churchwell, mD Chief Executive officer, Nemours
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Jefferson investigators who want pediatrics 
to be part of a study’s population will  
reach out to Nemours.
A Business case to Partner
As hospitals across the country wrestle with 
pressure to increase efficiency, healthcare 
partnerships are on the upswing, according 
to a March 2012 report by Moody’s Investors 
Service Inc. While hospitals have always 
looked to mergers as a way of becoming 
larger, some hospitals will join forces with 
once-unlikely partners — health insurers 
and for-profit companies — the report says. 
Pediatrics residents Matt Demczko, MD ’12, and  
Tracy Hills, DO, with a young patient at Nemours.  
Photo by Brad Gellman, courtesy of Nemours/
Alfred I. duPont Hospital for Children.
Academic medical centers are not immune 
to these challenges, and strategic partnering 
is quickly becoming a key component of 
long-term planning.
“We don’t have the luxury of thinking in 
monolithic, self-focused ways, like we did 
30 years ago,” says Schlaff. “frankly, unless 
it’s illegal or unethical, we can entertain 
any discussion.” 
one suggestion is to remake the relation-
ship between center city academic medical 
centers and community-based teaching 
hospitals. “We need a hub and spoke model, 
where the quaternary care academic center 
is the hub and strong relationships with 
community-based teaching hospitals go out 
like spokes on a wheel,” says david Paskin, 
Md ’64, vice dean for graduate medical 
education and affiliations. “That way you 
can have patient care delivered at the 
academic center or the community-based 
teaching hospital while maintaining access 
to the academic medical center if requested. 
our neuroscience network is an example of 
how this can work successfully. There is no 
sense economically with everyone having 
expensive technology and expertise in 
everything at every moment everywhere. 
The role of an academic center like Jefferson 
should be to provide those kinds of services 
and fortify the relationships that we have 
with the affiliates.”
greenspan agrees. “In the future, complex, 
challenging cases that other hospitals don’t 
want to deal with are going to come to a 
major academic hospital. A large segment 
of that could be young adults with special 
healthcare needs that have weathered the 
storms of the children’s hospital but are 
now looking for medical homes in the adult 
arena. There could be a business case made 
for tracking complex patients because we 
do it better, we do it cheaper and we do it 
with better access,” he says.
“If we take care of these mothers and 
these children, if we do this well and build 
new programs, it will be good for Jefferson 
and will have positive financial implications. 
We can articulate a vision that’s unique to 
us,” says Schlaff. “We can do it.” 
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The Match process, coordinated by the 
National Resident Matching Program 
annually since 1952, involves a computer 
algorithm that synchronizes applicants’ 
preferences with those of residency 
program directors to fill training slots 
across the country.
Although March 2012 brought the 
highest Match rate in 30 years — 95 percent 
of fourth-year allopathic students received 
residency placements — the future of grad-
uate medical education in the united States 
remains in limbo. The number of first-year 
residency applicants has swelled by more 
than 6,500 since 2001, but the number of 
positions available has not kept pace, 
increasing by a mere 3,000 over the  
same period. 
A freeze in federal support for gME has 
stifled the growth of residency opportunities, 
worrying healthcare experts who say 
America no longer has the capacity to train 
enough physicians to meet the public’s 
needs. Aging baby boomers, skyrocketing 
rates of chronic disease and the barrage  
of 30 million newly insured individuals 
under the Affordable Care Act will apply 
mounting pressure to an already over-
stretched system.
“u.S. medical schools have been 
expanding enrollment and are on track to 
increase capacity by 30 percent by 2016,” 
says darrell g. Kirch, Md, president and 
CEo of the Association of American 
Medical Colleges. “But without an increase 
in federal support to create more residency 
slots, we will not be able to avert the 
expected shortage of 90,000 physicians  
by 2020.” 
Competition up, Funding Down
In 2012, 815 fourth-year medical students 
failed to match, and that figure will grow in 
coming years, according to Thomas J. Nasca, 
Md ’75, CEo of the Accreditation Council for 
graduate Medical Education, an organization 
that accredits gME programs.
“We will not have nearly enough entry-
level residency positions for the combined 
graduating group of allopathic and  
osteopathic physicians by 2020 if current 
enrollment trends continue,” says Nasca, 
former dean of JMC. “The problem is not 
just that we won’t be able to meet the 
training needs of young physicians but that 
we won’t be able to meet the healthcare 
needs of the general public.”
The enrollment trends Nasca references 
involve schools’ responses to the AAMC’s 
projection of a shortage of 45,000 primary 
care physicians and 46,000 surgeons and 
specialists by 2020. Colleges and universi-
ties are steadily expanding class sizes to 
meet the demand for more physicians, and 
there are currently 18 new u.S. medical 
schools under development.
Regardless of the spike in enrollment, 
the number of federally funded residency 
training positions has remained frozen 
since the Balanced Budget Act of 1997. 
federal, state and private funds all 
contribute to gME, but Medicare covers 
the bulk — about $9.5 billion per year to 
support the salaries of residents and  
supervising physicians as well as to subsidize 
residency Program Limits: 
Can We Break the 
Training Bottleneck?
By Karen l. Brooks
 Story Summary
 Medical school enrollment is growing 
steadily, but the number of available 
residency slots is not.
 Concerns abound about new graduates’ 
ability to complete their training as  
well as the nation’s ability to meet the 
healthcare needs of a growing and 
aging population. 
 Federal support for graduate medical 
education has been frozen since 1997; 
physicians and some legislators are 
lobbying for increased funding.
For fourth-year medical students, “march madness” has 
nothing to do with basketball. They spend the first three 
weeks of the month anxiously awaiting match Day, when  
they will unseal the envelopes that hold their fates. 
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additional costs associated with running a 
training program, such as more patient 
testing. Recently, there have been multiple 
proposals to slash gME funding as 
Congress looks to cut federal spending; the 
Medicare Payment Advisory Commission 
and the National Commission on fiscal 
Responsibility and Reform have recom-
mended reductions as high as 50 percent.
Charles Pohl, Md ’87, senior associate 
dean for student affairs and career counseling 
at JMC, says these cuts could lead to a 
national crisis.
“What’s the point of graduating students 
with significant educational debt who can’t 
go on to complete their training and become 
physicians? This is a huge challenge for 
American health care, as it only increases 
the competition for the current residency 
spots without increasing the supply of  
practicing physicians — in the future, we’re 
not going to be able to meet workforce 
needs,” Pohl says.
As millions of people gain insurance for 
the first time, a shortage of primary care 
physicians poses the most significant work-
force concern. Nasca says academic health 
centers will have to “get creative” if gME 
funding decreases.
“Institutions can expand internal  
medicine, pediatrics and family medicine 
residency programs by ceasing to pay  
residents in more competitive programs 
like dermatology, orthopaedic surgery and 
radiology. They could use federal funds  
that previously supported the competitive 
programs to pay for new primary care  
positions and could start charging residents 
in the more competitive programs tuition,” 
Nasca says. 
“We could also see residencies become 
funded by device manufacturers or phar-
maceutical companies,” he says. “And the 
conflict of interest issues and influence on 
the physician’s future practice in that case 
would be disastrous.”
A Push for change
The Accreditation Council for graduate 
Medical Education estimated in a 2011 
report that a 50 percent reduction in 
Medicare gME funding would force the 
closure of 2,551 residency and fellowship 
programs and the loss of 33,023 gME  
positions across the country — results that 
would devastate young trainees as well  
as teaching hospitals, which depend on  
residents to provide patient care at a lower 
cost than attending physicians.
Joseph majdan, mD, congratulates a 
student at Jefferson match Day 2012.
With projected physician shortages in 
mind, legislators have drafted bills that aim 
to lift the 1997 gME funding cap. The 
Resident Physician Shortage Reduction and 
graduate Medical Education 
Accountability and Transparency Act, or 
HR 6352 — which was introduced in the 
House Aug. 2, 2012, and has a companion 
bill in the Senate — calls for Medicare to 
fund 15,000 new residency positions over 
the next five years. Another bill, HR 3667, 
proposes a Medicare-funded primary 
care residency pilot project in community-
based clinics and hospitals to fill healthcare 
gaps in rural and other underserved 
communities.
federal budget woes are likely to interfere 
with the system’s growth, though, and 
expanding gME programs is expensive. 
Nasca says the cost would be worth it.
“Residencies aren’t just about training — 
they are also about patient care. Think about 
the fact that there are 125,000 physicians in 
training right now, which is one of out 
every six practicing physicians. Residents 
provide an enormous amount of care, yet 
they account for less than 2 percent of the 
Medicare patient care spending budget,” he 
says. “Purely based on the amount of care 
that residents deliver, there should be more 
federal funding for gME.”
The Institute of Medicine, the health arm 
of the National Academy of Sciences,  
is also investigating gME issues. An 
18-member committee has been appointed 
to analyze the entire gME system, from 
regulation to financing to governance. The 
group will release its recommendations for 
improving gME by spring 2014.
“I am hopeful that the IoM committee 
will move beyond funding to talk about 
workforce needs and specialty distribution 
and that they will emphasize the need to 
better structure educational programs to 
meet the needs of the public,” Nasca says. 
Before 2012, students who failed to  
obtain a residency during the initial match 
resorted to a process called the “scramble.” 
On monday of match Week, students 
who learned they did not match could 
meet with their advisers to form a game 
plan for Tuesday, when a list of programs 
with available first-year positions was 
published. Tuesday at noon, they could 
start contacting unfulfilled programs with 
hopes of securing a slot. 
The scramble was chaotic and highly 
competitive — phone and fax lines would 
become clogged, and positions were 
filled quickly and often haphazardly. To 
streamline the process, last year the nrmP 
introduced the supplemental Offer and 
acceptance Program (sOaP). unmatched 
applicants now receive a list of unfilled 
positions on monday and can begin 
applying right away, but they cannot 
reach out to the program directors  
themselves. Instead, the programs began 
extending offers in eight rounds that start 
on Wednesday. applicants have two 
hours to make a decision after receiving 
an offer.
“The nmrP introduced sOaP to allow 
more time for communication between 
students and programs during match 
Week. But like any new process, it 
presented some challenges,” Charles 
Pohl, mD ’87, says. “The student affairs 
team was often removed from the  
equation — during the scramble, we  
were very present to advise our students 
about programs and career choices that 
matched their needs and to advocate for 
our stronger students to residency 
programs. But during sOaP, students 
were alone in the driver’s seat.”
Pohl says some students found that 
programs pressured them to commit 
immediately after receiving an offer 
regardless of the allotted two-hour 
window to ensure that their program  
filled the open position. 
“Programs didn’t want to remain 
unmatched any longer than they had to 
and sometimes pushed students to rush 
an acceptance, which was uncomfortable 
and unfair. This was not an outcome 
intended by the nrmP, though, and over 
time I do expect some of these kinks with 
sOaP to be worked out,” he says.
SoaP Cleans up the Scramble
Ibukun akinboyo and Victoria rose, 
both of the JmC Class of 2012, 
celebrate their match results.
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In 2012, people across the united States suffered more 
than 1 billion common colds — and chances are, you 
endured at least one of them. But how did you know 
it was just a cold and not a case of whooping cough?
Whooping Cough’s 
 ComebaCk and ConsequenCes
By Karen L. Brooks
{ }
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Scientists introduced a vaccine against whooping cough, or pertussis, more than 70 years ago, 
but recent surges show the illness is 
far from eradicated. last year brought 
the worst outbreak the nation has seen 
since 1959, with more than 39,000 cases 
reported to the Centers for disease 
Control and Prevention — more than 
twice the number reported in 2011. And 
experts know that many more cases  
went unrecognized.
“You really have to be looking for 
whooping cough to diagnose it in adults, 
since they often experience mild symp-
toms,” says Cynthia Hill, Md ’87, a 
pediatrician with Society Hill Pediatrics 
in Philadelphia. “The danger begins 
when these adults have contact with 
infants, because for them, whooping 
cough can be fatal.”
Whooping cough initially feels like a 
regular cold, but within weeks a violent 
and uncontrollable cough develops, 
lingering for up to three months. The 
highly contagious illness gets its name 
from the “whooping” sound made by 
those infected as they try to inhale 
during these bouts of coughing. 
In infants lacking antibody protection,  
coughing spells can be so harsh that 
eating, sleeping and breathing can 
become nearly impossible. Those who  
are not fully immunized may develop 
pneumonia or seizures, and more than half 
of babies who contract the illness must be 
hospitalized. Eighteen Americans, most of 
them infants, died from whooping cough 
in 2012. 
gary A. Emmett, Md ’76, says most of 
these deaths could have been prevented. 
“Whooping cough naturally follows a 
three- to five-year cycle, but there are 
other reasons we are seeing an increase,” 
says Emmett, a pediatrician with Nemours 
and director of hospital pediatrics at 
Jefferson. “unfortunately, most of those 
reasons involve human error or unjustified 
fear that can lead to very sick children.”
Why Cases Are Climbing
Whooping cough’s spike can be partially 
explained by an anti-vaccination move-
ment that has led many parents to 
decline immunizations for their children. 
In recent years, widespread statements in 
the media — including some from high-
profile celebrities — have linked vaccines 
to terrible health problems, causing panic 
among the general public. 
Although these claims have no scien-
tific basis, more and more families are 
forgoing vaccinations and contributing to 
outbreaks in the process. All u.S. states 
allow religious and medical exemptions 
for children’s vaccinations, but half of 
the whooping cough cases in 2012 came 
from six states that offer a personal or 
philosophical exemption, according to 
the CdC.
“People believe what they see on tele-
vision and the Internet over what they 
hear at the doctor’s office. So many 
people think you get sick from vaccines, 
but that’s not true,” Emmett says. “Those 
refusing vaccines have not seen a lot of 
disease or had personal experience with 
it, so they don’t realize how important 
vaccinations are. As we see more acute 
illness, they could get a rude awakening.” 
And even people who support vacci-
nation can fall victim to whooping 
cough. A reformulated vaccine has 
proved weaker than its predecessor, and 
immunity wanes over time. In 1997, 
the original “whole cell” dTwP vaccine 
— which protected against diphtheria, 
tetanus and pertussis and contained 
entire, dead pertussis bacteria — was 
phased out because of concerns about 
side effects like high fevers and sore 
limbs. But the new vaccine, the acellular 
dTaP given to infants and children up 
to age 7, gradually loses effectiveness, 
dropping to about 70 percent protection 
within five years.
“The medical community made a 
conscious decision to reduce side effects 
but ended up inadvertently changing 
the long-term immunogenicity of the 
vaccine. It’s still a great vaccine — it just 
doesn’t give you permanent immunity, 
and you need boosters throughout life,” 
Emmett says.
But a booster called Tdap for teens and 
adults also weakens after a few years, and 
many adults don’t even realize they need 
it. The CdC reports that just 8 percent of 
American adults have received the Tdap 
booster since it became available in 2006.
“Many adult patients don’t know 
to ask about Tdap, and clinicians who 
treat adults aren’t always used to giving 
vaccines like pediatricians are,” Emmett 
says. “Vaccinating is an expensive 
process that requires a lot of staff time. 
Not all adult practitioners have those 
resources, and if they aren’t giving shots 
frequently, it’s hard to keep them around. 
They expire, and that costs money.”
Stopping the Spread
Even though the newer vaccine doesn’t 
last as long as the old one, experts say 
vaccination is still the best way to avoid 
whooping cough. Vaccination reduces 
 Story Summary
 a recent resurgence of whooping  
cough has alarmed healthcare experts.
 weaker vaccines and fear of  
vaccinations have contributed  
to the spike in cases.
 pediatricians and other physicians  
need to educate their patients on  
the importance of vaccination.
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Pediatrician Cynthia Hill, mD ’87, vaccinates a 2-month-old patient. Photo by sabina Pierce.
“Our biggest push as pediatricians is to immunize  
anyone who will be taking care of an infant: parents, 
grandparents, siblings, babysitters. When I educate  
my patients and their families about the importance  
of immunizations, they are more likely to comply.”
– Cynthia Hill, mD ’87
the risk of infection and of passing the 
infection along if you do get sick. It also 
results in shorter, less severe symptoms. 
In an effort to better protect infants, 
an advisory panel for the CdC recom-
mended last year that pregnant women 
get a pertussis booster shot after their 
20th week of pregnancy. This not only 
protects mothers but also passes anti-
bodies along to fetuses in the womb for 
earlier protection in the first months  
of life.
Currently, the dTaP vaccine is admin-
istered at ages 2, 4 and 6 months, then 
again at 15 to 18 months and finally at 
4 to 6 years. A booster is recommended 
at 11 or 12, but studies are examining 
whether it should be given earlier than 
that, perhaps at 8 or 9, to better protect 
children in their preteens.
The food and drug Administration 
has approved the Tdap booster as a one-
time injection for adults through age 
64 in lieu of a regular tetanus shot, but 
physicians expect guidelines to change 
soon to call for repeated boosters every 
decade.
“our biggest push as pediatricians is 
to immunize anyone who will be taking 
care of an infant: parents, grandparents, 
siblings, babysitters. When I educate 
my patients and their families about the 
importance of immunizations, they are 
more likely to comply,” Hill says.
Emmett agrees that education is essen-
tial. “There is no way to make everyone 
get vaccinated. But what people need to 
realize is that vaccines aren’t for individ-
uals — they’re for society. When you opt 
out of getting a vaccine for your child, 
you endanger not just your child, but all 
children,” he says. “People need to feel 
more of a group identity rather than only 
taking responsibility for themselves.” 
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Jefferson faculty
Robert L. Brent, MD, PhD:   
An International Authority on Congenital disorders
Bob Brent can’t explain what drew him to the field of medicine. 
Nobody in his family had attended college, let alone medical school, 
and he didn’t have any physician role models as a child. But even in 
his youth, he somehow sensed his calling.
“When I was 8, I decided that I was going to be a physician who 
didn’t charge his patients,” he says. “My mother didn’t think that 
sounded very practical.”
Brent wasn’t deterred and went on to fulfill his dream. one of 
the world’s leading experts in radiation biology, developmental 
biology, embryology and teratology, he has been providing free 
reproductive risk assessments to women and families for more 
than 50 years.
Raised in Rochester, N.Y., Brent didn’t hesitate before pursuing 
his ambitions. Knowing he would be drafted into World War 
II after high school, he took his advanced exams early and was 
accepted to the university of Rochester at age 15. As a student, he 
held a job with the Manhattan Project (later the Atomic Energy 
Commission), researching the effects of radiation on developing 
embryos. This work provided the foundation for his entire career.
The war ended before the date of Brent’s u.S. Army induction 
notice, so he completed his bachelor’s degree at just 18. “getting 
into medical school as a teenager wasn’t easy. I applied to 86 
schools over the next three years,” says Brent, who continued his 
radiation research the whole time.
finally accepted to the university of Rochester School of 
Medicine and dentistry at 21, Brent received his Md in 1953 and  
a Phd in embryology and radiation biology in 1955 and did a  
pediatric residency at Massachusetts general Hospital. He then 
served two years in the Army, heading the radiation biology 
section at the Walter Reed Army Institute of Research, where he 
was involved in monitoring radiation exposure resulting from 
nuclear bomb testing programs.
After his military service, Brent joined Jefferson’s faculty 
and advanced to become chair of pediatrics, a role he held for 
three decades. He is now the distinguished louis and Bess Stein 
Professor of Pediatrics, Radiology and Pathology and head of the 
Clinical and Environmental Teratology laboratory at the Alfred 
I. duPont Hospital for Children in Wilmington, del. — a major 
Jefferson partner. The author of nearly 500 scientific publications, 
including six books and four movies, Brent has won many awards 
for his achievements, such as Castle-Connolly Physician of the 
Year; the Alfred I. duPont Award for Excellence in Children’s 
Health Care; and election to the Institute of Medicine of the 
National Academies.
Although he rarely works in the clinic these days, Brent 
continues to counsel patients as an expert editor for the online 
community of the Health Physics Society, a group of specialists 
in radiation safety. As leader of the site’s pregnancy section, he 
conducts about 2,000 free consultations per year for pregnant 
women and families who have been exposed to potentially toxic 
agents. He recently surpassed his 25,000th assessment.
Brent’s charitable activities extend beyond free health  
counseling. He and his wife of 63 years, lillian, have established 
four scholarships at Jefferson and in 2011 created the Robert and 
lillian Brent Alumni giving Incentive fund to inspire generosity 
among JMC graduates. The Brents made a donation that places funds 
in each new graduate’s account for five years, resulting in 100 percent 
giving participation for that class. They hope that after five years, 
alumni will be motivated to maintain this status on their own.
“The gratification and joy of sustaining an institution of educa-
tion is a very rewarding part of life,” Brent says.
And while Brent might not have encountered many physician 
role models growing up, he has certainly served as one for  
subsequent generations. His sons, david and larry, are JMC 
alumni, and his daughter, deborah, graduated from the Jefferson 
School of Nursing. This past fall, his granddaughter, Elyssa, began 
her first year at JMC.
Brent recently shared reflections on his profession.
Q: What brought you to Jefferson back in 1957?
A:  After I was discharged from the Army, I received four job 
offers, but Jefferson’s was exceptional. The university offered 
me four laboratories, my own animal facility and the rank of 
associate professor, even though I was only 29 years old. Also, 
the chairman of obstetrics and gynecology, dr. Thaddeus 
Montgomery, interviewed me and was a real class act, just such 
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an impressive and ethical person. I thought that if this was the 
kind of faculty that Jefferson employed, it had to be a good place.
Q:  You’ve enjoyed a lengthy career. What advice would you give 
students going into medicine today?
A:  don’t be discouraged by the pressures and responsibilities that 
come with being a physician — they are all worthwhile. No 
other profession will give you more satisfaction or allow you to 
make a greater contribution to the world. You will constantly  
be stimulated by new discoveries, so take every opportunity to 
learn. I am 85 years old and still learn at least five things every day.
Q:  Have you ever considered retiring?
A:  No, because I always look forward to going to work and because 
I am still helping patients through my Web consultations. 
Women who believe that they have been exposed to toxic agents 
reach out for a second opinion after their physicians may have 
recommend interrupting a wanted pregnancy. I never tell a 
patient what to do — I explain risks and let them make their 
own decisions. Sometimes, their exposure was so low that 
drastic measures aren’t necessary, and I help them understand 
that and save lives in the process.
Q:  What inspired you to establish scholarship funds at Jefferson?
A:  I believe that education should be free. Tuition these days is 
just too high for a young person to handle. There is nothing 
more important than education, and my family wants to make 
medical education attainable.
Q:  What is your proudest professional accomplishment?
A:  first, the growth I oversaw in Jefferson’s department of 
Pediatrics. When I became acting chairman, I had three 
faculty members and a very small budget. By the time I became 
emeritus chairman 30 years later, our main pediatrics site had 
moved to the Nemours/duPont Hospital for Children with 
140 faculty members and a budget of about $125 million. The 
Nemours programs are now among the largest in the country 
and a great source of pride for me. 
    Second, my research. I couldn’t counsel my patients without 
having completed so much basic research in reproductive biology, 
embryology and toxicology. People I have met or taught over the 
years might someday forget me, but my research publications 
will live on forever. The medical literature chronicling all of the 
new knowledge I uncovered — that is my legacy. 
     — Karen L. Brooks
Photo by Cynthia Brodoway, courtesy of 
nemours/alfred I. duPont Hospital for Children.
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Bar-Ad Named Residency  
Program Director
Voichita Bar-Ad, Md, associate professor in 
the department of Radiation oncology, has 
been named director of the department’s resi-
dency program. Bar-Ad primarily treats head 
and neck and gastrointestinal cancer cases 
and maintains a research focus on treatment-
related side effects and toxicities, patient 
quality of life and symptom management.
Waldman Receives NCI Grant
Scott Waldman, Md, Phd, chairman of 
the department of Pharmacology and 
Experimental Therapeutics, has been 
awarded a prestigious “Provocative Questions” 
grant from the National Cancer Institute as 
part of its program to tackle “important but 
not obvious” questions related to cancer.  
out of 700 applicants nationwide, just 57 
recipients were chosen.
Headlines
Loss of Protein Linked to  
Critical Limb Ischemia
Restoring diminished levels of a protein 
shown to prevent and reverse heart failure 
damage could also help patients with critical 
limb ischemia (ClI), researchers from 
Jefferson’s Center for Translational Medicine 
suggest in a preclinical study published 
online oct. 9, 2012, in Circulation Research.
low levels of the protein S100A1 have 
been linked to congestive heart failure and 
high blood pressure and now appear to be 
associated with critical lower limb ischemia, 
a condition found in type 2 diabetic patients 
where blood flow to legs is cut off, often 
resulting in amputation. Past studies have 
shown that returning the protein to normal 
levels or above prevented and/or reversed 
congestive heart failure in large animal 
models with gene therapy. given these new 
findings, the researchers posit that S100A1 
could also be a potential therapeutic target in 
ClI to promote revascularization.
The team was led by lead author Patrick 
Most, Md, adjunct assistant professor 
of medicine, and senior author Karsten 
Peppel, Phd, associate professor in the 
Center for Translational Medicine.
New Function of ATP Discovered
Jefferson researchers have unraveled a new 
function of adenosine triphosphate, or ATP, 
beyond its passive roles as an energy source 
and a phosphate donor for phosphorylation 
reactions. Their studies revealed a new 
model of kinase regulation, whereby ATP 
modulates an “on-off-switch” mechanism 
in Akt — a serine/threonine-specific 
protein kinase that plays a key role in 
KnudsenWaldmanBar-ad
People
on the Boardwalk – 
with the Clintons
This past June, Jeffrey Joseph, DO, 
director of research in the Department 
of anesthesiology, had a chance 
encounter with former President Bill 
Clinton and secretary of state Hillary 
Clinton on the boardwalk in Ventnor, 
n.J. Pictured with Hillary Clinton 
are Joseph; his wife, Celia; and his 
daughter, amanda.
Waldman’s four-year, $1.2 million grant 
will support his studies into the relationship 
between obesity and cancer. He is specifically 
looking at a hormone receptor known as 
guanylyl cyclase C (gCC), found mostly in 
the intestinal tract, and how its levels affect 
cancer risk.
Knudsen Named Journal Editor
Karen E. Knudsen, Phd, professor of cancer 
biology, urology and radiation oncology and 
deputy director for basic science the Kimmel 
Cancer Center, has been named editor-in-
chief of Molecular Cancer Research, one  
of the American Association for Cancer 
Research’s seven major peer-reviewed journals. 
Molecular Cancer Research publishes 
original, novel and well-designed studies 
on the molecular and cellular aspects of 
cancer biology. Knudsen began her term  
in January 2013.
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multiple cellular processes such as glucose 
metabolism, apoptosis, cell proliferation, 
transcription and cell migration — by 
inducing conformational changes in the 
Akt kinase domain. The three members of 
the Akt protein kinase family play key roles 
in multiple cellular processes, including 
glucose metabolism; cell survival and 
proliferation; and cell migration. 
A molecular switch that affects the acti-
vation state of specific Akt isoforms may be 
exploited to modulate Akt signal strength 
in malignant diseases, as well as in diabetes 
and diseases of the heart and the central 
nervous system. 
The data was reported in the Proceedings 
of the National Academy of Sciences and 
was the subject of a perspective in Science 
Signaling in its May 2012 issue.
Study Connects Empathy  
and Outcomes
Patients of doctors who are more empathic 
have better outcomes and fewer complica-
tions, according to an empirical study by a 
team of Jefferson and Italian researchers who 
evaluated relationships between physician 
empathy and clinical outcomes among 
diabetic patients and physicians in Italy. 
The study, published in the September 
2012 issue of Academic Medicine, serves 
as a follow-up to a smaller Jefferson study 
published in the same journal in March 2011.
“This new, large-scale research study has 
confirmed that empathic physician-patient 
relationships is an important factor in posi-
tive outcomes,” said Mohammadreza Hojat, 
Phd, research professor in the department 
of Psychiatry and Human Behavior and 
Hojat
 
director of the Jefferson longitudinal Study 
of Medical Education in the Center for 
Research in Medical Education and Health 
Care at JMC. “Compared to our initial 
study, it has a much larger number of 
patients and physicians, a different tangible 
clinical outcome, hospital admission  
for acute metabolic complications and a 
cross-cultural feature that will allow for 
generalization of the findings in different 
cultures and different health care systems.”
Contrast-Enhanced Ultrasound 
Better Detects Prostate Cancer 
led by principal investigator and Prostate 
diagnostic Center Co-director Ethan 
Halpern, Md, researchers have found that 
contrast-enhanced ultrasound detects 
high-grade prostate cancer better than 
conventional methods, making it a more 
appropriate approach for screening clinically 
important cancers and monitoring low-risk 
ones with fewer biopsies. Their phase III 
study was published online in September 
2012 in the Journal of Urology. 
findings from the randomized, double-
blind trial revealed the technique, which 
uses microbubbles to measure change in 
blood flow, found almost three times as 
many higher-grade cancers using half as 
many needle biopsies compared to system-
atic biopsy methods.
Protein Could Help Guide  
Prostate Cancer Treatment
Men who had high levels of the activated 
Stat5 protein in their prostate cancer after 
a radical prostatectomy were more likely to 
have a recurrence or die from the disease 
compared to men who had little to no 
presence of the growth protein, according 
to a study published in Human Pathology 
by researchers from the Kimmel Cancer 
Center at Jefferson. The findings suggest 
that Stat5 — which, when activated, signals 
cancer cells to grow and survive — could 
be an ideal biomarker to help guide patients 
and physicians for future treatment. 
The team, led by Marja Nevalainen, Md, 
Phd, associate professor of cancer biology, 
medical oncology and urology, examined 
prostate cancer biopsies and tumor tissues 
obtained from 562 men who underwent 
a radical prostatectomy, comparing Stat5 
levels with outcome. They also looked at 
prostate tumor tissue in 106 patients who 
were under a “watchful waiting” or active 
surveillance treatment plan and had no 
neoadjuvant therapy.
Tumor Tracking Technique  
May Improve Lung Cancer  
Patient Outcomes
Medical physicists at Jefferson and the 
Kimmel Cancer Center have discovered a 
tumor-tracking technique that delivers higher 
levels of radiation to moving tumors while 
sparing healthy tissue in lung cancer patients.
Researchers have been searching for 
ways to better track tumors — which are  
in constant motion because of breathing — 
in order to up the dosage during radiation 
therapy without increasing side effects. 
They have now shown that their real-time 
tracking technique can achieve such tasks. 
The results of the study, which was led by 
Ivan Buzurovic, Phd, a medical physics 
resident and researcher in the department 
Buzurovic
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of Radiation oncology, and Yan Yu, Phd, 
vice chair and director of medical physics, 
were published in the November 2012 issue 
of Medical Physics.
Brazilian Mediums Shed Light on 
Brain Activity During Trance State
A study by researchers at Jefferson and the 
university of Sao Paulo in Brazil analyzed 
the cerebral blood flow of Brazilian mediums 
during the practice of psychography, 
described as a form of writing whereby  
a deceased person or spirit is believed to 
write through the medium’s hand, and 
revealed decreased brain activity during 
mediumistic dissociative state that generated 
complex written content. The mediums 
were injected with a radioactive tracer  
to capture their brain activity during 
normal writing and during the practice  
of psychography, which involves the 
subject entering a trance-like state. The 
subjects were scanned using single photon 
emission computed tomography to  
highlight the areas of the brain that are 
active and inactive during the practice. 
“This first-ever neuroscientific evaluation 
of mediumistic trance states reveals some 
exciting data to improve our understanding 
of the mind and its relationship with the 
brain. These findings deserve further 
investigation both in terms of replication 
and explanatory hypotheses,” says Andrew 
Newberg, Md, director of research at the 
Jefferson-Myrna Brind Center of Integrative 
Medicine. The findings appeared in the 
Nov. 16, 2012, edition of the online  
journal PLOS ONE.
Medical Frontiers
Older Age Marker Needed for 
Papillary Thyroid Cancer Prognosis 
Jefferson researchers have shown that age 
45 is no longer a useful outcome predictor 
in the staging of papillary thyroid cancer 
patients. Since the 1970s, physicians have 
used age at diagnosis to determine the 
severity of these cancers. Papillary thyroid 
cancers — those including affected lymph 
nodes — diagnosed before age 45 are  
designated as Stage 1, while the same 
cancers with lymph node involvement 
presenting after age 45 years are Stage 3.
The team analyzed 45,390 thyroid cancer 
cases diagnosed between 2001 and 2007 and 
reviewed five-year survival rates. The most 
significant drop was seen in those aged 65 
to 74 years, though prognosis was still good 
at 92 percent.
“With time, we have developed new  
therapies and surgical techniques, leading to 
better survival rates,” says Jeffrey l. Miller, 
Md, co-director of the Thyroid Center at 
Jefferson. “We feel that age 45 is no longer 
an appropriate age designation to influence 
papillary thyroid cancer prognosis.”
NIH Grant to Fund Skin  
Disease Study
Researchers at the Jefferson Institute of 
Molecular Medicine have been awarded 
almost $384,000 by the National Institutes 
of Health to investigate the mechanisms 
involved in the development of a serious 
and sometimes fatal disease, nephrogenic 
systemic fibrosis, which is a rare skin 
disorder linked to gadolinium-based 
contrast agents used in magnetic  
resonance (MRI and MRA) studies.
The team, led by Sergio A. Jimenez, 
Md, co-director of the Jefferson Institute 
of Molecular Medicine and director of the 
Jefferson Scleroderma Center, aims to gain 
a better understanding of the molecular 
mechanisms behind the initiation of the 
disorder in order to develop possible new 
treatments. They will investigate the role 
of specialized cells known as macrophages 
and their cell surface receptors known as 
Toll-like receptors in gadolinium-based 
contrast agent induced skin fibrosis.
Combining Therapies Cuts 
Angioplasty, Stenting Complications
Jefferson researchers have shown that 
combining distal protection devices with 
prophylactic use of the drug nicardipine is 
more effective at preventing life-threatening 
complications following a percutaneous 
coronary intervention such as angioplasty 
or stenting on patients who have under-
gone previous bypass surgery than distal 
protection devices alone.
Angioplasty or stenting on bypass 
vessels is associated with a high risk of 
complications due to distal embolization, 
the dislodging of plaque and clots down-
stream, impairing blood flow and leaving 
patients at risk for a heart attack. distal 
protection devices are commonly used to 
prevent blockages by catching the dislodged 
plaque and clot in a basket-like device, 
allowing blood to filter through the 
bypassed artery. Still, complications 
remain in up to 10 percent of patients. 
Preliminary studies have suggested that 
prophylactic doses of nicardipine, a 
common intracoronary vasodilator, can 
miller Jimenez savage ParviziYu newberg
  
also help in this regard, but never have  
the two techniques been combined.
“Through the combined power of these 
two therapies, we have a new approach 
that is improving outcomes for this high 
risk subset of patients,” says Michael P. 
Savage, Md, director of Jefferson’s Cardiac 
Catheterization lab.
Deviating from Radiation  
Protocols Increases Risks
Ensuring that radiation therapy protocols 
are followed not only decreases deviations 
but can improve overall survival in cancer 
patients, Jefferson researchers suggested 
in a first-of-its kind study presented at the 
American Society for Radiation oncology 
54th Annual Meeting in october 2012.
faculty from the department of Radiation 
oncology analyzed radiation therapy  
protocols, quality assurance measures and 
patient outcomes in eight large clinical trials 
to determine if deviations were associated 
with inferior clinical outcomes. Examples  
of radiation therapy deviation include  
inadequate targeting of high-risk lymph 
node regions or incorrect dose calculation. 
Their findings revealed that deviating from 
protocols was associated with up to a 75 
percent increased risk of treatment failure and 
mortality. This suggests that implementing 
quality assurance measures to ensure 
protocols are followed could improve 
outcomes for cancer patients, according  
to the authors.
Aspirin as Successful as  
Warfarin in Preventing Clots
If you’ve had joint replacement surgery, 
you’ve likely been given warfarin, a 
common blood thinner and clot-preventer, 
prior to surgery. Researchers from the 
Rothman Institute at Jefferson have 
shown aspirin to be just as effective in 
preventing clots — specifically pulmonary 
emboli, life-threatening blood clots that 
can develop in the arteries of the lungs 
following joint replacement surgery. Their 
research was recognized as one of the 
best poster presentations at the recent 
American Association of Hip and Knee 
Surgeons meeting in dallas. 
“While warfarin is successful in the 
prophylactic prevention of clots it can also 
lead to increased bleeding, infections and 
hospital readmissions,” says Javad Parvizi, 
Md, director of research at the Rothman 
Institute and lead author of the study.
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10th Annual Jefferson Awards gala
Jefferson hosted its sold-out 10th annual awards Gala Oct. 25 
at the Hyatt at the Bellevue in Philadelphia. every year, this event 
honors two members of the Jefferson community whose leader-
ship has profoundly affected the field of medicine. 
Honorees for 2012 were William Keane, mD, the Herbert Kean 
Professor and Chair of the Department of Otolaryngology-Head 
and neck surgery and medical director of Jefferson university 
Physicians; and robert nicoletti, a local business leader and 
philanthropist whose family has established two endowed 
professorships at Jefferson.
The 2012 gala raised more than $700,000 to support two  
initiatives selected by the awardees. Gifts honoring Keane will 
benefit an education legacy fund supporting otolaryngology  
resident training programs, and gifts honoring nicoletti will 
provide scholarship funding for Jefferson medical College 
students in need of financial assistance. 
The Jefferson community is grateful to all who helped to  
make this year’s gala a resounding success.
Pictured (from left) are TJu President richard Gozon; gala honoree William Keane, mD, and his wife, Louise; gala honoree robert nicoletti; and TJuH 
President David mcQuaid, FaCHe.
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Cynthia L. Sears, MD ’77:  
A Life’s Work Inspired by Service Overseas
Alumna Profile
In spring 1979, Cynthia Sears found herself 
in a Cambodian refugee camp triaging 
35 vomiting, dehydrated children. The 
patients, all from a camp orphanage, had 
been fed contaminated food, and with the 
help of two nurses, it was up to Sears to 
care for them — not to mention the dozens 
of other refugees with infectious diseases 
occupying her residency group’s make-
shift emergency ward. “It was experiences 
like that that made me realize I wanted to 
pursue a career in infectious diseases over 
gI medicine,” she says.
growing up in Pottstown, Pa., Sears 
thought she would follow in the footsteps 
of her mother and become a nurse. But 
her father encouraged her to dream bigger 
and become a doctor. So as a junior in 
high school, Sears applied for the five-year 
joint undergraduate and medical degree 
program through Penn State and JMC. She 
interviewed for the program her senior 
year, was accepted, and went off to Happy 
Valley and eventually, Philadelphia.
But toward the end of her internal 
medicine residency and fellowship at Cornell 
Medical Center (now Weill), Sears remained 
undecided if she should apply for a fellowship 
in infectious disease or gI medicine. Around 
the same time, her residency group was 
given the opportunity by the International 
Rescue Committee to run an emergency 
room in a Cambodian refugee camp. So she 
went to the camp in Thailand.
“I saw an astonishing array of infectious 
disease, including diarrheal illnesses and 
childhood illnesses,” says Sears. “Because of 
the policies of Pol Pot, there was limited 
immunity to common childhood illnesses 
built up in the population. When the  
refugees were crowded in the camp, there 
were outbreaks of childhood diseases and 
more — measles, mumps, rubella, chicken 
pox, meningitis and cholera. I was in the 
middle of it.”
She came back to the united States and 
completed one year of the internal medicine 
fellowship at Cornell, then applied for 
infectious disease fellowships. While waiting 
for acceptance, Sears went to Memorial Sloan-
Kettering to study with donald Armstrong, 
Md, her attending at the refugee camp and 
head of infectious diseases at Sloan-Kettering. 
At that point, it was 1981, and HIV had hit 
New York City. “That was an amazing year,” 
she recalls. “I had a remarkable experience 
watching this epidemic unfold and manifest 
as opportunistic infections.”
After her year at Sloan-Kettering, Sears 
completed her infectious disease fellowship 
at the university of Virginia. By then, she 
had decided to train to become an enteric 
pathogen expert — a process she says  
is ongoing.
Having worked at Johns Hopkins 
university School of Medicine for the past 
25 years, Sears, a professor of medicine in 
infectious diseases and gastroenterology, 
is now studying a bacterium called entero-
toxigenic Bacteroides fragilis (ETBf). She 
was originally examining how toxins made 
by bacteria might contribute to diarrheal 
disease. But in working with ETBf, her 
team learned that it linked to an oncologic 
pathway. They tested the hypothesis that 
ETBf may induce tumors in the colon, 
and those experiments proved positive. “In 
research you end up with a few moments, 
a few experiments, over the course of your 
career that really make you rock back on 
your heels and think more deeply,” she says. 
This was one of them.
Now her team is working to understand 
the mechanisms that cause bacteria to  
be oncogenic in the colon and how the 
microbiome contributes to the pathogenesis 
of colon cancer — a task that will be her life’s 
work. “I’ve considered taking on a leadership 
position, but I think I am going to work 
away at this question of how bacteria may 
influence colon cancer,” she says. “I hope we 
can come up with a new approach to prevent 
a disease that is extremely common.” 
In her spare time, Sears is involved 
with Moveable feast, a Baltimore-based 
nonprofit with a mission to provide 
nutritious food at no cost to low-income 
individuals with life-threatening diseases, 
particularly HIV and cancer. Besides sitting 
on the board of directors of Moveable feast 
and volunteering to deliver food, Sears 
participates in fierce Chicks Rock, a bike 
team that completes an annual 140-mile 
ride called Ride for the feast to raise funds 
for Moveable feast.
But whether she’s working with Moveable 
feast or in the lab at Hopkins, Sears 
remembers the refugee camp and the career 
clarity it provided her. “There are times when 
I realize I am really enjoying my job because 
aspects remind me of the refugee camp,” she 
says. “Those five months made a big impact.”
 
— Elizabeth Seasholtz
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ClassNotes
William Harrer, Courtney 
Malcarney, Joseph Sokolowski 
and Stephen Vasso joined together 
to organize a private celebration 
during their 50th reunion weekend 
in october. Malcarney and his wife, 
Kay, provided their home; Vasso 
and his wife, Edna, provided the 
wine; and Harrer and Sokolowski’s 
wives, Carol and Maureen, 
provided the food. The classmates 
would like to express thanks to 
their peers for their participation 
in reunion weekend and to Phillip 
Marone, MD ’57, MS ’07, and 
Toni Agnes of the alumni relations 
office at JMC and everyone at the 
Jefferson foundation for their help 
with this year’s reunion events.
’64
John P. Whitecar writes that he 
is proud of his two daughters, 
Linnane R. Batzel, MD ’99, and 
Colleen J. Whitecar, MD ’06, 
both of whom graduated from 
Jefferson. Whitecar continues to 
enjoy practicing hematology  
and oncology in Columbus, Miss.
’67
Anthony Padula is medical director 
for Independence Blue Cross in 
Philadelphia, where he lives.
Elliot Rayfield is an endocrinologist 
and clinical professor of medicine 
at the Mount Sinai School of 
Medicine in New York. He serves 
as co-chair of the Endocrine 
Society’s Sawin library and 
Resource Center. 
’70
Peter Pizzutillo has served as 
director of orthopaedic surgery 
and associate surgeon-in-chief 
at St. Christopher’s Hospital for 
Children for nearly two decades. 
He reports that “the clinical 
care, educational and research 
activities and mentoring of young 
associates at this institution have 
provided me with a stimulating 
and energizing career.” Pizzutillo 
lives in Wynnewood, Pa.
’72
Robert McKay splits his time 
between practicing anesthesi-
ology and holistic medicine. He is 
currently studying acupuncture, 
myofascial release, therapeutic 
yoga and reiki. McKay lives in 
Bristol, Tenn.
James Redka practices family 
medicine in Williamsport, Pa. 
He is a board member for the 
Pennsylvania Medical Society 
and the lycoming County Health 
Improvement Coalition and is 
chairman of the board of the 
Susquehanna Community Health 
and dental Center.
William Wixted continues to work 
full time at his private urology 
practice. He lives in linwood, N.J.
’75
Joseph J. Korey is still actively 
practicing obstetrics and gyne-
cology. He and his wife, linda, live 
in Reading, Pa., and celebrated 
their 40th anniversary in June 2012.
’76
David W. Willis recently 
returned to the east coast after 
30 years in oregon, having been 
recruited to the Health Resources 
and Services Administration’s 
Maternal Child Health Bureau as 
director of the division of Home 
Visiting and Early Childhood 
Systems. This work involves 
building early childhood invest-
ments to address the social 
determinants of health, education 
and social capacities of our most 
vulnerable children. Willis now 
lives in Bethesda, Md.
’78
Alexander Mamourian was 
recently promoted to full professor 
of radiology at the university of 
Pennsylvania. He sends his thanks 
to the Jefferson faculty who 
supported him during his time at 
JMC and his best wishes to all of 
his classmates. Mamourian lives 
in Wayne, Pa.
Michael P. Russo reports that he 
is semi-retired from an oB/gyn 
practice in York, Pa. He enjoys 
traveling with his wife, Barbara, 
visiting their sons in Naples, fla., 
and Erie, Pa.
’80
Angela E. Lin reports that she 
enjoys working as a medical 
geneticist at Massachusetts 
general Hospital and recently 
was promoted to clinical 
professor at Harvard Medical 
School. lin has applied her 
previous training in pediatric 
cardiology to her current work 
in cardiovascular genetics 
and coordinates the Turner 
Syndrome Clinic and Hereditary 
Hemorrhagic Telangiectasia 
Center. lin writes that her 
highlights from 2012 included 
receiving the service award 
from the National Birth defects 
Prevention Network; seeing 
classmate Marianne T. Ritchie, 
MD ’80, named the new JMC 
Alumni Association president; 
and unexpectedly running into 
classmate John C. Wain, MD ’80, 
now director of thoracic surgical 
research and the surgical director 
of MgH’s lung transplant 
program, in an elevator at MgH. 
After 15 years working in the 
same institution, lin and Wain 
promised to do lunch very soon.
’81
Stuart Gordon is the division 
head for adult hip and knee recon-
struction at Cooper university 
Hospital in Camden, N.J. He 
lives in Haverford, Pa., with his 
wife, Marianne Ritchie, MD ’80, 
president of the JMC Alumni 
Association.
’82
Judd Moul is director of the duke 
Prostate Center and the James H. 
Semans, Md, Professor of Surgery 
at the duke university School of 
Medicine. He and his wife, Ellen, 
live in Chapel Hill, N.C.
’47
Joseph Corson is a surgical 
pathologist currently focusing on 
malignant mesothelioma. He is a 
professor of pathology at Harvard 
Medical School and lives in 
lexington, Mass.
’53
Thurman Gillespy Jr. is founder 
and senior partner of the 
orthopaedic Clinic of daytona 
Beach, fla., a nine-physician 
orthopaedic group that includes 
his two sons, Albert, MD ’82, and 
Mark, MD ’86, as well as Gilbert 
Martin, MD ’54. gillespy stopped 
performing surgeries four years 
ago but still sees office patients 
part time and serves on several 
committees at the area hospital.
’57
Vincent Cuddy retired from 
practicing surgery in 1996. He 
is a volunteer faculty member 
in the university of Pittsburgh’s 
department of Surgery and 
Anatomy. Cuddy has 18 grandchil-
dren and lives in Beaver falls, Pa.
Abram Hostetter retired from 
psychiatry practice in 2003 and 
lives in a retirement community in 
Charlottesville, Va. He enjoys taking 
care of his son’s three-acre lawn  
and garden and is still involved in  
a genetic research project.
’61
Jerry Harrell recently reconnected 
with Ed Downing, MD ’64, at a 
medical mission seminar and remi-
nisced about work in Mombasa, 
Kenya. downing and his wife, lois, 
are dear friends of Harrell, who 
lives in St. Simons Island, ga.
’62
Harry Candela retired in 1994 
after 30 years with the u.S. 
Navy. He now volunteers with 
the Nemours program “Healthy 
Habits for life,” a childhood 
obesity prevention initiative, in 
orlando, fla. Candela lives in 
Maitland, fla.
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’85
David S. Seres has been promoted 
to associate professor of clinical 
medicine at the Columbia 
university College of Physicians 
and Surgeons and Institute of 
Human Nutrition. Seres recently 
was appointed to the Medical 
Advisory Board of Consumer 
Reports. He lives in New York City.
’87
Mark D. Falls has a private ophthal- 
mology practice in Vienna, Va., and 
is involved with residency training 
at georgetown university Hospital/ 
Washington Hospital Center.
’97
Christopher Doty recently 
accepted a position as vice chair of 
education and program director 
for the university of Kentucky’s 
emergency medicine department. 
He and his wife, laurie, have left 
their longtime home in Brooklyn, 
N.Y., for a new southern adventure.
’98
Philip C. Ovadia welcomed his 
second daughter, layla Mackenna, 
in November 2012. ovadia practices 
cardiothoracic surgery with 
Heritage Valley Health System and 
lives in Beaver, Pa., with his wife, 
Shelly, and 2-year-old daughter, Eva.
’02
Rita M. Pechulis has been appointed 
medical director of the medical 
intensive care unit at lehigh Valley 
Hospital’s Cedar Crest campus. 
She has two children, Emelia and 
Samuel, and lives in Macungie, Pa.
’08
Holly Simpson and Gerard Berry 
Jr. were married on June 30, 2012, 
at the Pennsylvania Academy of 
fine Arts. The groom’s father, 
Gerard Berry Sr., is a JMC graduate 
from the Class of 1975.
Laura Snyder is a fifth-year 
neurosurgery resident at the 
Barrow Neurological Institute at 
St. Joseph’s Hospital and Medical 
Center in Phoenix, where she lives.
let’s talk technology. oK, so I don’t have a 
smart phone. No problem. My “dumb phone” 
keeps me connected just fine, and it’s still more 
convenient than a pay phone. 
What’s that? You’re aghast that my 8-year-
old Toyota has no gPS? That’s oK. Stopping 
for directions at gas stations leads to making 
new friends.
As of oct. 1, 2012, federal regulations 
mandate that all medical records be electronic; 
we no longer have a choice about documentation. 
on the bright side, now we can tap into 
universal records with notes from colleagues, 
lab and X-ray results and medication lists. 
Even better, we can access the information 
from the hospital, office or home. Another plus 
is not worrying about misplaced charts in a big 
office. And no more jokes about doctors’ illegible 
handwriting. The printed word is definitely 
easier on the eye.
But beware — the new world of Electronic 
Medical Records isn’t perfect.
1. Make use of free-texting. The drop-down 
selections do not always offer the options I 
might want to include when I’m completing 
a history and physical. An effective clinician 
captures the specific nuances in each patient’s 
history and physical. A fill-in-the-blank 
template doesn’t always lend itself to commu-
nicating the exact details that distinguish the 
belly pain of a virus from appendicitis, or  
irritable bowel from inflammatory bowel.
2. look the patient in the eye. Students learn 
the value of appreciating the Hippocratic facies — 
the expression on the patient’s face. How can we 
win a patient’s trust if our back is turned while we 
type on the computer keyboard?
3. do not depend on spell check. Read your 
notes before you click “finalize.” on many 
occasions, I have dictated a letter to a referring 
doctor. When reviewing the typed draft, I have 
found the words “unfortunately, the biopsies 
were negative for cancer,” when in fact I had 
recorded the words “Fortunately, the biopsies 
were negative for cancer.” This error would go 
undetected if I depended on spell check. 
4. Read notes critically. The document isn’t 
more official or valid just because it’s printed.  
Remember, it’s not hard to “click and send” an 
error, such as ordering milligrams of a drug 
rather than micrograms.
5. Reference “Copied and Pasted and 
Misdiagnosed (or Cloned Notes and Blind 
Alleys),” a very informative article written  
by our Jefferson colleague, dr. Susan Rattner, 
that suggests EMR makes it easy to cut and 
paste other clinicians’ notes. “The process of 
composing a note encourages critical thinking; 
copying a note does not.”  Students and residents 
need to start from scratch, take their own 
histories to learn the process, but also because 
the history is dynamic.  Symptoms and signs 
often change between the time of the initial 
exam and later exams. A patient may 
remember additional vital information when 
repeating the history the third or fourth time.
6. Pick up the phone and call your colleague. 
direct communication with another physician 
allows for more accurate exchange of details 
and more importantly, the chance to brainstorm 
ideas. Such collaboration leads to safer, more 
efficient and cost-effective patient care.
So no need to say goodbye to the flinstones 
and leave the stone-age town of Bedrock 
for orbit City. The Jetsons don’t live in 
nirvana, either. live somewhere in between 
by embracing the advantages of technology 
but sticking to the basics of a conscientious, 
methodical, thinking clinician.
Marianne T. Ritchie, Md ’80
President, JMC Alumni Association
Alumni Association 
President’s Message
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’65
Albert A. Dubin, 85, of gilbert, 
Ariz., died Aug. 25, 2012. dubin is 
survived by his daughter, lisa; his 
son, Michael; eight grandchildren; 
and one great-grandchild.
’69
Benjamin P. Seltzer, 67, of New 
orleans, la., died oct. 22, 2012. 
Seltzer was a neurologist who 
researched Alzheimer’s disease 
and taught at the medical schools 
of Harvard, Boston university 
and Tulane, which he left after 
Hurricane Katrina. He returned 
to Harvard and the Boston VA 
before becoming director of 
the Program in Cognitive and 
Behavioral Neurology at Barrow 
Neurological Institute in Phoenix. 
He served on the Scientific 
Advisory Board of the Arizona 
Alzheimer’s Consortium. Seltzer 
is survived by his wife, Natalie; his 
mother, Sylvia; a sister, Marjorie 
Stanek, Md, who is on the faculty 
at Jefferson; his children, daniel, 
Jennifer, Peter and Nathan; and 
two grandchildren.
Post-Graduate
’71
Shlomo Friedman, of dallas, died 
feb.12, 2012, of natural causes. 
friedman was a pediatrics resident 
at Jefferson from 1968 to 1971 and 
a Cardeza Research fellow from 
1971 to 1972.
InMemoriam
’44J
Irvin Gerson, 93, of Bala Cynwyd, 
Pa., died oct. 18, 2012. gerson was 
a family practitioner, neurological 
researcher and faculty member at 
JMC. He is survived by his wife, 
Rosalie; five children; and eight 
grandchildren.
’44S
Herbert S. Hunter, 94, of 
Sacramento, Calif., died feb. 19, 
2012. Hunter had a successful 
career as an ear, nose and throat 
specialist. He retired from private 
practice in 1986, then served in 
the u.S. Air force for three years 
as flight surgeon at McClellan Air 
force Base and established the 
Hearing Preservation Clinic. He 
was preceded in death by his wife 
of more than 60 years, lois.
’46
A. Joseph Cappelletti, 90, of 
Pinehurst, N.C., died April 4, 
2012. Cappelletti served as class 
president at JMC. He was a lieu-
tenant in the u.S. Navy from 1955 
to 1957. Throughout his career, he 
was affiliated with Waterbury 
Hospital in Connecticut, where he 
established the first coronary care 
unit in the state and served as 
chief of medicine and chief of 
staff. He survived by his wife of  
61 years, Norma, and four sons.
Melvin L. Reitz, 89, of Kutztown, 
Pa., died June 15, 2012. He was a 
u.S. Army veteran of World War 
II and practiced family medicine 
in Tower City, Pa., for 35 years.  
He is survived by his wife, three 
children, five grandchildren and 
three great-grandchildren.
Seymour Krevsky, 92, of 
Bloomfield, Ill., died July 11, 
2012. Krevsky practiced pediatric 
medicine for 50 years. He is 
survived by his wife, Margery, 
and a stepson, Joseph Stearns.
’47
Luther F. Corley Jr., 87, died in 
September 2011. Corley practiced 
family medicine in Boaz, Ala., for 
more than 45 years after serving 
in the military in Korea and was 
instrumental in the formation of 
the Boaz-Albertville Hospital. He 
is survived by his wife, Clare; two 
sons, Trey, MD ’79, and Tom, MD 
’80; and three grandchildren.
’49
Richard Murphy Whittington 
died Nov. 20, 2012, in Palm Coast, 
fla. After graduating from JMC 
and serving in the u.S. Army in 
Korea and at Walter Reed Army 
Hospital, Whittington joined the 
Veterans Administration in 1952. 
He held a number of positions 
within VA including chief of staff 
at the Cleveland VA Hospital and 
associate deputy chief medical 
director at VA Headquarters in 
Washington. He became chief of 
staff at the gainesville VA Medical 
Center in 1976 and served as asso-
ciate chief of staff for geriatrics 
and extended care from 1992 to 
1999. After 52 years of government 
service, Whittington continued 
serving the VA in his retirement 
as a consultant in geriatric medi-
cine to the VA network director in 
florida. He was preceded in death 
by his first wife, Eileen; his second 
wife, Joan; and his son, david. He 
is survived by his sister, one son, 
three daughters, two stepchildren, 
five grandchildren and three  
step-grandchildren.
’50
H. William Schmidt, 91, of King 
of Prussia, Pa., died Aug. 21, 2012. 
Schmidt, a pathologist, was retired 
from Montgomery Hospital in 
Norristown, Pa. He is survived by 
his wife, Marina; his son, Mark; 
and two grandchildren.
’54
Bernard B. Borkowski, 86, of 
New Hope, Pa., died July 19, 2012. 
He completed his internship in 
general surgery and residency in 
general, vascular and thoracic 
surgery at Jefferson and remained 
on the medical staff until 1973. 
He retired in 1993 as an emer-
gency department physician at 
grandview Hospital in Sellersville, 
Pa. Borkowski is survived by his 
wife, Barbara, a 1958 Jefferson 
diploma nursing graduate; and 
two daughters.
’57
Bertram H. Frohman, 84, of 
Yardley, Pa., died Aug. 10, 2012. 
After serving in the Korean War, 
frohman established a family 
medicine practice in Trenton, 
N.J., and later in Hamilton, N.J., 
serving the community for over 50 
years. He is survived by his wife, 
Mary; and seven stepchildren.
’58
William Joseph Thomas, 79, of 
Hyannis, Mass., died oct. 4, 2012. 
After graduating from JMC, Thomas 
joined the u.S. Navy and established 
a distinguished career in adult 
psychiatry. He worked at several 
hospitals in addition to maintaining 
a large private practice in Norwood 
and dover, Mass., for more than 20 
years. A lifelong lover of music, 
Thomas was an accomplished pianist. 
He is survived by his wife, grace A. 
Murphy; and four children.
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JMC Alumni Online Community
In fall 2011, JMC launched a private online networking community strictly for alumni. The site not only publishes 
Jefferson news and event information but also enables grads and post-grads to create personal profiles and connect 
with peers and classmates for both social and professional reasons. You control your profile and decide how much 
information to share, from contact information to photographs to LinkedIn profiles. 
The community is constantly changing and expanding. Visit connect.jefferson.edu/medicalcollege to join and explore.
By THENumbers
JMC graduates listed in the  
community’s online directory: 
    19,344
Class year with the greatest 
community participation: 
                    1977
Top five countries sending  
the most visitors to the site: 
1 United States 
2 Canada 
3 India 
4 United Kingdom 
5 Germany
Non-alumni who can view 
your profile: 
Your constituent ID, needed for log-in:
 Unique to you!
Find your ID number on the mailing label  
on the back cover of this magazine.
Number to call if you need your ID  
number or have trouble registering: 
 215-955-4354
0 (Your secrets are safe with us!)
Categories of events 
posted on the site: 
3 (JMC alumni events, CME and national meetings)
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Now it’s easier than 
ever to stay connected!
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1.   Visit connect.jefferson.edu and select the MedICalCollege  
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2.  Click “register now” in the upper right-hand corner.
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Explore tools and resources at connect.jefferson.edu/medicalcollege today!
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